Celgene Endorses Presage Biosciences’ Cancer Drug Analysis Platform with Strategic Collaboration
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 4 (Table of Contents)
Published: 1 Apr-2013
DOI: 10.3833/pdr.v2013.i4.1912 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Celgene has formed a strategic collaboration with Presage Biosciences, a spin-off from the Fred Hutchinson Cancer Research Center, to use the company’s three-dimensional in vivo drug analysis technology to identify novel drug combinations for the treatment of patients with solid tumours...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS